Citation Tools

Download PDFPDF

Original article
Phosphodiesterase type-5 inhibitor use in type 2 diabetes is associated with a reduction in all-cause mortality

Download to a citation manager

Cite this article as:
Anderson SG, Hutchings DC, Woodward M, et al
Phosphodiesterase type-5 inhibitor use in type 2 diabetes is associated with a reduction in all-cause mortality